Skip to main content
HighlightsHighlights Archive

Media Monitoring: 16 – 22 September

By September 21, 2023No Comments

UK announces “transformational” support to boost global health at UNGA

  • new UK government funding will help tackle future pandemics, boost research into vaccines and reduce deaths from infectious diseases and end preventable deaths of mothers, new-borns and children
  • package shows commitment to helping achieve the UN’s Sustainable Development Goals, a set of key targets to make the world a better place by 2030
  • Up to £295 million of funding for health research and development partnerships to support the development of accessible and affordable new vaccines, drugs, medical devices, and diagnostics


Work begins on £42m specialist lab space at Manchester’s internationally significant health innovation campus

  • Bruntwood SciTech, a 50:50 joint venture between Bruntwood and Legal & General dedicated to the growth of the science and technology sector, has commenced construction on a £42m, 125,000 sq ft specialist lab and office workspace at the Citylabs cluster to strengthen Manchester’s internationally significant health innovation campus.
  • The seven-storey development incorporates infrastructure to accommodate CL2 labs and specialist equipment, including increased floor loading, enhanced cooling systems and ventilation provisions, and a large platform lift.
  • Citylabs is surrounded by some of the UK’s most eminent teaching hospitals including the Royal Manchester Children’s Hospital, Manchester Royal Infirmary (with emergency helipad access), Saint Mary’s Hospital and the Manchester Royal Eye Hospital.


Green light for Oxford North’s next three advanced R&D lab buildings totalling 458k sq ft

  • Detailed designs for three new, prestigious laboratory and office buildings which total 458,100 sq ft (42,549 sq m) and will be built as phase two of Oxford North, the new £700 million life sciences innovation district, have been resolved to be approved by Oxford City Council’s planning committee.
  • Oxford North will deliver one million sq ft (92,903 sq m) of laboratory and workspaces, 480 new homes, hotel, nursery, cafes, bars, three public parks and infrastructure.


Genetic tests could lead women to have unnecessary breast surgery

  • Women could be opting to have unnecessary surgery to avoid breast cancer, after being told they are at high risk from genetic test results.
  • However, these genetic test results do not take family history into account.
  • A new study warns that women who discover, outside of a clinical setting, that they carry a disease-causing variant in one of the breast cancer genes (BRCA1 or BRCA2) may be told their risk of breast cancer is 60 to 80%.
  • In fact, the risk could be less than 20% if they do not have a close relative with the condition.

UK scientists develop 10-minute blood test to diagnose diseases (Paywall)






Ben Kemp